Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vatalanib + FOLFOX in first-line metastatic colorectal cancer
NCT00056459Phase 3Completed
- Sponsor
- Novartis
- Start
- Feb 2003
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 3 trial of vatalanib in metastatic colorectal cancer (mCRC), sponsored by Novartis. Started Feb 2003; status: completed.
02
Drugs
vatalanib
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00056459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00056459.